Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02465892 · ClinicalTrials.gov registry record · NA
Pillars4Life Trial
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 284
- Enrollment target
NCT02465892: Completed NA study, sponsored by Duke University.
NCT02465892 is a NA study that has completed, run by Duke University. The registered enrollment target is 284 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02465892, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 284 participants
- Enrollment target
Study Summary
This study aims to explore whether cancer patients can benefit from completing the Pillars4Life online coping program. This randomized control trial will have half its subject completing the program and the other half receiving standard care in order to measure whether the program is beneficial in dealing with stress, anxiety, and particularly chronic pain that often accompany a cancer diagnosis.
Primary Outcome
Subjects will report how much chronic pain they have and how they are coping with it.
Interventions
- BEHAVIORAL Pillars4Life
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT02465892 record still lists
NCT02465892 is an interventional study that assigns participants to a tested intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which Pillars4Life is the first listed.
NCT02465892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02465892 about?
NCT02465892 is a clinical study titled "Pillars4Life Trial". This study aims to explore whether cancer patients can benefit from completing the Pillars4Life online coping program. This randomized control trial will have half its subject completing the program and the other half receiving standard care in order to measure whether the program is beneficial in d...
What is the current status of trial NCT02465892?
This trial is currently completed. It is a NA study. The enrollment target is 284 participants. The study started on 2015-05. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02465892?
The interventions under investigation include: Pillars4Life (BEHAVIORAL).
Who is sponsoring clinical trial NCT02465892?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02465892's enrollment target sits among peer trials
284 377th of 2000 higher than 1,623 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
- NCT06963034 · 284 participants · Phase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia